Clinical Trials on Locally Advanced Unresectable Gastric Adenocarcinoma in Korea, Democratic People's Republic of
Total 274 results
-
Bristol-Myers SquibbCompletedLocally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal JunctionFrance, Poland, Russian Federation, Taiwan, United States, Hong Kong, Spain, Germany, Italy, Japan, Korea, Republic of, Singapore
-
Txinno Bioscience Inc.RecruitingLocally Advanced (Unresectable) or Metastatic Solid TumorsKorea, Republic of
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Korea, Republic of, China, Spain, Taiwan, Japan, Argentina, Canada, Croatia, Greece, Ireland, Malaysia, Netherlands, Portugal, Romania, Thailand, Turkey, United Kingdom
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
Samsung Medical CenterCompletedAdvanced Gastric AdenocarcinomaKorea, Republic of
-
Samsung Medical CenterCompletedAdvanced Gastric AdenocarcinomaKorea, Republic of
-
Yonsei UniversityCompletedAdvanced Gastric AdenocarcinomaKorea, Republic of
-
Samsung Medical CenterCompletedAdvanced Gastric AdenocarcinomaKorea, Republic of
-
Samsung Medical CenterTerminatedAdvanced Gastric AdenocarcinomaKorea, Republic of
-
Gangnam Severance HospitalRecruitingGastro-esophageal Junction Cancer | Relapsed or Advanced Gastric AdenocarcinomaKorea, Republic of
-
Samsung Medical CenterCompletedAdvanced Gastric AdenocarcinomaKorea, Republic of
-
CHA UniversityRecruitingLocally Advanced CholangiocarcinomaKorea, Republic of
-
Genexine, Inc.CompletedLocally Advanced or Metastatic Solid TumorsKorea, Republic of
-
Asan Medical CenterRecruitingResectable Gastric or Gastroesophageal Junction AdenocarcinomaKorea, Republic of
-
Yonsei UniversityCompletedHepatocellular Carcinoma, Unresectable, AdvancedKorea, Republic of
-
AmgenTerminatedAdenocarcinoma of the Pancreas | Locally Advanced | UnresectableSpain, Belgium, Denmark, Poland, United States, Korea, Republic of, Russian Federation, Austria, Portugal, United Kingdom, Germany, Hungary, Czech Republic
-
Cho Hyun ParkPeking University; The Catholic University of KoreaWithdrawnStage IV or Unresectable Gastric CancerKorea, Republic of
-
National Cancer Centre, SingaporeHoffmann-La Roche; Sirtex Medical; Singapore Clinical Research InstituteRecruitingLocally Advanced Hepatocellular CarcinomaKorea, Republic of, Singapore
-
Samsung Medical CenterCompleted
-
Seoul National University HospitalSeoul National University Bundang Hospital; SMG-SNU Boramae Medical CenterActive, not recruitingLocally Advanced or Metastatic NSCLCKorea, Republic of
-
Yonsei UniversityRecruitingGastric AdenocarcinomaKorea, Republic of
-
Yonsei UniversityCompletedGastric AdenocarcinomaKorea, Republic of
-
Samsung Medical CenterCompleted
-
Vaxcell Bio, Co., Ltd.CompletedLocally Advanced Hepatocellular CarcinomaKorea, Republic of
-
Samsung Medical CenterCompletedGastric Outlet Obstruction Due to Gastric AdenocarcinomaKorea, Republic of
-
Gilead SciencesEverest MedicinesActive, not recruitingLocally Advanced or Metastatic Unresectable Urothelial CancerUnited States, Belgium, France, Spain, United Kingdom, Korea, Republic of, Czechia, Germany, Israel, China, Italy, Australia, Hong Kong, Taiwan, Portugal, Singapore, Croatia, Greece, Turkey, Sweden, Switzerland, Canada, Austria, Bulgaria and more
-
Yonsei UniversityCompleted
-
Do-Youn OhAstraZenecaActive, not recruitingAdvanced Gastric CancerKorea, Republic of
-
Samsung Medical CenterCompletedAdvanced Gastric CancerKorea, Republic of
-
Samsung Medical CenterCompletedAdvanced Gastric CancerKorea, Republic of
-
Asan Medical CenterCompletedAdvanced Gastric CancerKorea, Republic of
-
Asan Medical CenterCompletedAdvanced Gastric CancerKorea, Republic of
-
Asan Medical CenterRoche Pharma AGCompletedAdvanced Gastric CancerKorea, Republic of
-
Yonsei UniversityTerminatedAdvanced Gastric CancerKorea, Republic of
-
Seoul National University HospitalCompletedAdvanced Gastric CancerKorea, Republic of
-
Samsung Medical CenterCompletedAdvanced Gastric CancerKorea, Republic of
-
Yonsei UniversityUnknownGastric AdenocarcinomaKorea, Republic of
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal JunctionUnited States, Spain, Italy, Australia, Russian Federation, Taiwan, Korea, Republic of, Thailand, Canada, Turkey, Germany, Romania, United Kingdom, Hungary, Brazil, France, Japan
-
Yonsei UniversityRecruitingAdvanced Gastric CancerKorea, Republic of
-
Asan Medical CenterCompletedAdvanced Gastric CancerKorea, Republic of
-
Asan Medical CenterNational Cancer Center, Korea; Chonbuk National University Hospital; Samsung... and other collaboratorsCompletedAdvanced Gastric CancerKorea, Republic of
-
Seoul National University HospitalCompletedAdvanced Gastric CancerKorea, Republic of
-
Yonsei UniversityCompletedMetastatic Advanced Gastric CancerKorea, Republic of
-
Seoul National University HospitalPfizerCompletedAdvanced Gastric Cancer | HER2Korea, Republic of
-
Kangbuk Samsung HospitalRecruitingHER2-positive Advanced Gastric CancerKorea, Republic of
-
Elevar TherapeuticsTerminatedGastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedActive, not recruitingMetastatic Solid Tumor | Locally Advanced Solid TumorKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedNational OncoVentureCompletedHER-2 Positive Advanced Gastric CancerKorea, Republic of
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | Gastric Cancer Third LineSpain, Italy, Australia, Korea, Republic of, Belgium, France, Poland, United States, Czechia, Germany
-
Asan Medical CenterRecruitingGastric or Gastroesophageal Junction(GEJ) AdenocarcinomaKorea, Republic of